001     128231
005     20240228145537.0
024 7 _ |a 10.1002/mp.12251
|2 doi
024 7 _ |a pmid:28370020
|2 pmid
024 7 _ |a 0094-2405
|2 ISSN
024 7 _ |a 1522-8541
|2 ISSN
024 7 _ |a altmetric:18379224
|2 altmetric
037 _ _ |a DKFZ-2017-04248
041 _ _ |a eng
082 _ _ |a 610
100 1 _ |a Wieser, Hans-Peter
|0 P:(DE-He78)59c02b7b30ad8972cf422bb1c955956c
|b 0
|e First author
245 _ _ |a Development of the open-source dose calculation and optimization toolkit matRad.
260 _ _ |a New York, NY
|c 2017
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1511261326_9860
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a We report on the development of the open-source cross-platform radiation treatment planning toolkit matRad and its comparison against validated treatment planning systems. The toolkit enables three-dimensional intensity-modulated radiation therapy treatment planning for photons, scanned protons and scanned carbon ions.matRad is entirely written in Matlab and is freely available online. It re-implements well-established algorithms employing a modular and sequential software design to model the entire treatment planning workflow. It comprises core functionalities to import DICOM data, to calculate and optimize dose as well as a graphical user interface for visualization. matRad dose calculation algorithms (for carbon ions this also includes the computation of the relative biological effect) are compared against dose calculation results originating from clinically approved treatment planning systems.We observe three-dimensional γ-analysis pass rates ≥ 99.67% for all three radiation modalities utilizing a distance to agreement of 2 mm and a dose difference criterion of 2%. The computational efficiency of matRad is evaluated in a treatment planning study considering three different treatment scenarios for every radiation modality. For photons, we measure total run times of 145 s-1260 s for dose calculation and fluence optimization combined considering 4-72 beam orientations and 2608-13597 beamlets. For charged particles, we measure total run times of 63 s-993 s for dose calculation and fluence optimization combined considering 9963-45574 pencil beams. Using a CT and dose grid resolution of 0.3 cm(3) requires a memory consumption of 1.59 GB-9.07 GB and 0.29 GB-17.94 GB for photons and charged particles, respectively.The dosimetric accuracy, computational performance and open-source character of matRad encourages a future application of matRad for both educational and research purposes.
536 _ _ |a 315 - Imaging and radiooncology (POF3-315)
|0 G:(DE-HGF)POF3-315
|c POF3-315
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
700 1 _ |a Cisternas, Eduardo
|0 P:(DE-HGF)0
|b 1
700 1 _ |a Wahl, Niklas
|0 P:(DE-He78)dfd5aaf608015baaaed0a15b473f1336
|b 2
700 1 _ |a Ulrich, Silke
|0 P:(DE-He78)84f1e7432f32ce7df9064fa665afc191
|b 3
700 1 _ |a Stadler, Alexander
|0 P:(DE-He78)efcc1c3a629fc60fadc148f74c88811e
|b 4
700 1 _ |a Mescher, Henning
|0 P:(DE-He78)c2ae1305c3f54907b473d564b973e424
|b 5
700 1 _ |a Müller, Lucas-Raphael
|0 P:(DE-He78)8d14cee85833a37a0fa389fbf7552025
|b 6
700 1 _ |a Klinge, Thomas
|0 P:(DE-HGF)0
|b 7
700 1 _ |a Gabrys, Hubert
|0 P:(DE-He78)ee06f8e4345f9f83ac70f0bce435f58a
|b 8
700 1 _ |a Burigo, Lucas Norberto
|0 P:(DE-He78)914adea2baeb4f2c6a29637da6500048
|b 9
700 1 _ |a Mairani, Andrea
|b 10
700 1 _ |a Ecker, Swantje
|b 11
700 1 _ |a Ackermann, Benjamin
|b 12
700 1 _ |a Ellerbrock, Malte
|b 13
700 1 _ |a Parodi, Katia
|b 14
700 1 _ |a Jäkel, Oliver
|0 P:(DE-He78)440a3f62ea9ea5c63375308976fc4c44
|b 15
|u dkfz
700 1 _ |a Bangert, Mark
|0 P:(DE-He78)fec480a99b1869ec73688e95c2f0a43b
|b 16
|e Last author
773 _ _ |a 10.1002/mp.12251
|g Vol. 44, no. 6, p. 2556 - 2568
|0 PERI:(DE-600)1466421-5
|n 6
|p 2556 - 2568
|t Medical physics
|v 44
|y 2017
|x 0094-2405
909 C O |o oai:inrepo02.dkfz.de:128231
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 0
|6 P:(DE-He78)59c02b7b30ad8972cf422bb1c955956c
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 1
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 2
|6 P:(DE-He78)dfd5aaf608015baaaed0a15b473f1336
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 3
|6 P:(DE-He78)84f1e7432f32ce7df9064fa665afc191
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 4
|6 P:(DE-He78)efcc1c3a629fc60fadc148f74c88811e
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 5
|6 P:(DE-He78)c2ae1305c3f54907b473d564b973e424
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 6
|6 P:(DE-He78)8d14cee85833a37a0fa389fbf7552025
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 7
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 8
|6 P:(DE-He78)ee06f8e4345f9f83ac70f0bce435f58a
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 9
|6 P:(DE-He78)914adea2baeb4f2c6a29637da6500048
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 15
|6 P:(DE-He78)440a3f62ea9ea5c63375308976fc4c44
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 16
|6 P:(DE-He78)fec480a99b1869ec73688e95c2f0a43b
913 1 _ |a DE-HGF
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-315
|2 G:(DE-HGF)POF3-300
|v Imaging and radiooncology
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
|b Gesundheit
914 1 _ |y 2017
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b MED PHYS : 2015
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Thomson Reuters Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
920 1 _ |0 I:(DE-He78)E040-20160331
|k E040
|l Medizinische Physik in der Strahlentherapie
|x 0
920 1 _ |0 I:(DE-He78)E210-20160331
|k E210
|l Translationale Radioonkologie
|x 1
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)E040-20160331
980 _ _ |a I:(DE-He78)E210-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21